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Introduction
The  maintenance  of  an  intact  genome  is  crucial  for  cellular   
homeostasis. DNA double-strand breaks (DSBs), generated by 
ionizing radiation (IR) and radiomimetic drugs, are the most cyto-
toxic lesions. Failure to repair DSBs causes genomic instabil-
ity and can lead to tumorigenesis and other age-related diseases 
(Jackson and Bartek, 2009). Upon DSB induction, cells acti-
vate a DNA damage response (DDR) that comprises two major 
stages: initial sensing of DNA breaks followed by downstream 
events leading to cell cycle arrest, DNA damage repair, and sub-
sequent cell cycle resumption.
Numerous  factors  involved  in  DSB  processing,  signal-
ing, and repair accumulate at damaged sites in focal structures 
termed IR-induced foci (IRIF). Within seconds, DSBs are de-
tected  by  the  Mre11–Rad50–Nbs1  (MRN)  and  Ku70–Ku80 
complexes,  which  in  turn  recruit  the  apical  PI3-kinase–like 
kinases  (PIKKs),  ataxia  telangiectasia  mutated  (ATM),  and 
DNA-dependent protein kinase catalytic subunit (DNA-PKcs), 
respectively  (Falck  et  al.,  2005). A  prime  PIKK  target  is 
the C terminus of the histone variant H2AX, whose derivative 
phosphorylated on serine 139 (S139) is referred to as H2AX 
(Rogakou et al., 1998). Phospho-S139 of H2AX is then bound 
by the tandem BRCA1 C-terminal domain (BRCT) domains of 
the DDR-mediator protein MDC1 (mediator of DNA damage 
checkpoint 1; Stucki et al., 2005). ATM-mediated phosphory-
lations near DSB sites are propagated via phospho-dependent 
recruitment of MRN-ATM by MDC1, thus helping to cre-
ate  megabase-sized  H2AX-MDC1  foci  (for  review  see   
van Attikum and Gasser, 2009). MDC1 phosphorylated by ATM 
also recruits the RING-finger ubiquitin E3-ligase RNF8, which, 
together with another ubiquitin E3-ligase, RNF168, produces 
DSB-associated ubiquitylations on histones H2A and H2AX 
that, in turn, promote accumulation of p53-binding protein 1 
(53BP1) and breast cancer gene 1 (BRCA1) proteins (Huen   
et al., 2007; Kolas et al., 2007; Mailand et al., 2007; Doil et al., 
2009; Pinato et al., 2009; Stewart et al., 2009). These ubiquity-
lation events are thought to contribute to local changes in the 
chromatin structure near break sites to facilitate DSB signaling 
and repair.
Although DDR has been extensively studied in interphase 
cells, its precise mechanisms and functions in mitotic cells are 
still poorly understood. The onset of mitosis is characterized by 
nuclear envelope disassembly and the regulated compaction of 
T
he signaling cascade initiated in response to DNA 
double-strand  breaks  (DSBs)  has  been  extensively 
investigated  in  interphase  cells.  Here,  we  show 
that mitotic cells treated with DSB-inducing agents acti-
vate a “primary” DNA damage response (DDR) com-
prised of early signaling events, including activation of 
the protein kinases ataxia telangiectasia mutated (ATM) 
and DNA-dependent protein kinase (DNA-PK), histone 
H2AX phosphorylation together with recruitment of me-
diator of DNA damage checkpoint 1 (MDC1), and the 
Mre11–Rad50–Nbs1 (MRN) complex to damage sites. 
However, mitotic cells display no detectable recruitment of 
the E3 ubiquitin ligases RNF8 and RNF168, or accumula-
tion of 53BP1 and BRCA1, at DSB sites. Accordingly, we 
found that DNA-damage signaling is attenuated in mitotic 
cells, with full DDR activation only ensuing when a DSB- 
containing mitotic cell enters G1. Finally, we present data 
suggesting that induction of a primary DDR in mitosis is im-
portant because transient inactivation of ATM and DNA-PK 
renders mitotic cells hypersensitive to DSB-inducing agents.
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arrested cells (Xu and Stern, 2003) were capable of binding to 
the H2AX phospho-epitope in peptide pull-down experiments, 
as was MDC1 from extracts of asynchronous cells (Fig. 1 C).
We next assessed whether IRIF formation in mitotic cells 
required ATM and DNA-PK kinase activities. By using small-
molecule inhibitors specific to each kinase (Hickson et al., 
2004; Leahy et al., 2004), we observed partial redundancy be-
tween the two kinases in mediating H2AX phosphorylation 
and IRIF formation (Figs. 1 B and S2, A and B). Consistent 
with previous studies (Burma et al., 2001; Hickson et al., 2004; 
Stiff et al., 2004; Wang et al., 2005), ATM inhibition reduced 
IRIF intensity, whereas combined ATM and DNA-PK inhibi-
tion almost completely abrogated IRIF in both M-phase and 
interphase cells. DNA-PK inhibition alone did not visibly   
affect the DDR markers (Fig. S2 B and not depicted). In line with 
DNA damage leading to ATM activation in mitotic cells, we 
detected the S1981-phosphorylated form of ATM (Bakkenist and 
Kastan, 2003) in extracts of IR-treated mitotic cells (Fig. S2 C; 
van Vugt et al., 2010). Furthermore, in accord with ATM acti-
vation being mediated by the MRN complex (Williams et al., 
2007), NBS1 colocalized with H2AX in mitotic cells treated 
with IR (Fig. 1 D).
Exclusion of 53BP1 from mitotic IRIF 
precedes its association with IRIF in G1
Having established that mitotic cells respond to DSB induc-
tion by phosphorylation of H2AX and by the recruitment of 
MDC1 and MRN to DSB sites, we next examined the behavior 
of another mediator protein, 53BP1, which in interphase cells 
associates with IRIF within 5 min of IR exposure (Schultz et al., 
2000). By using an anti-53BP1 antibody or U2OS cells stably 
expressing GFP-53BP1, we found that, in marked contrast to 
interphase cells, during mitosis, 53BP1 was mostly excluded 
from chromatin and was not recruited to IRIF (Fig. 2, A–D; and 
Fig. S3, A–C). The punctate staining of 53BP1 on condensed 
pro-metaphase chromosomes in both untreated and irradiated 
cells, which never colocalized with H2AX (Fig. 2, A and B), 
is consistent with previously reported 53BP1 association with 
kinetochores (Jullien et al., 2002). Importantly, 53BP1 protein 
levels were similar during the cell cycle, and, in agreement with 
an earlier study (Jullien et al., 2002), 53BP1 in nocodazole- 
arrested cells displayed slower gel mobility due to hyper-
phosphorylation in mitosis (Fig. 3 D). The finding that 53BP1 
also did not form IRIF in mitotic HeLa, BJ, or MRC5 cells   
(Fig. S3 B) demonstrates that 53BP1 exclusion from mitotic 
chromatin is not cell-line specific.
To determine whether 53BP1 is actively excluded from 
IRIF  upon  mitotic  entry,  we  irradiated  asynchronously  grow-
ing U2OS cells in the presence or absence of AZD7762, an in-
hibitor of the DNA-damage checkpoint kinases Chk1 and Chk2 
(Zabludoff et al., 2008), then measured mitotic indices by FACS 
with an antibody against histone H3 phosphorylated on serine 
10 (H3pS10; Juan and Darzynkiewicz, 2004). In the undam-
aged samples, both mock- and Chk1 inhibitor–treated, 1.5% 
of cells were in mitosis (Fig. 2 C). After a 2-h phleomycin treat-
ment, this dropped to 0.4% because the G2/M checkpoint pre-
vents damaged interphase cells from proceeding into mitosis, 
chromatin into mitotic chromosomes, which is essential for the 
subsequent separation of sister chromatids in anaphase. Notably, 
vertebrate cells can delay mitosis, or even reverse mitotic pro-
gression if exposed to IR during antephase (late G2 to mid pro-
phase) when chromatin condensation is actively taking place 
(Pines and Rieder, 2001; Chin and Yeong, 2009). However, once 
cells have passed a “point-of-no-return,” they are committed to 
completing mitosis even in the presence of DSBs (Rieder and 
Cole, 1998). The rate of mitotic progression can nevertheless be 
affected by the amount of DNA damage (Mikhailov et al., 2002). 
DNA breaks do not hinder mitotic progression per se, and do 
not appear to induce activation of a DNA damage checkpoint 
(Rieder and Salmon, 1998). Nevertheless, H2AX foci do form 
in mitotic cells treated with IR (Nakamura et al., 2006; Kato et al., 
2008), which suggests that DSBs generated during mitosis are 
not left unnoticed by the DDR machinery. Here, we show that 
mitotic cells treated with DSB-inducing agents exhibit apical 
aspects of the DDR but not a full DDR. We also provide evi-
dence that marking of DSBs generated in mitosis with H2AX 
enhances cell viability, which suggests that it acts to facilitate 
full DDR induction in the more favorable chromatin environ-
ment of the G1 cell.
Results and discussion
Mitotic DSBs are marked by PIKK-
dependent H2AX, MDC1, and MRN foci
H2AX is a hallmark of unrepaired DSBs in interphase cells 
(Rogakou et al., 1998; Paull et al., 2000). Several studies have 
described focal or pan-nuclear H2AX staining in mitotic cells 
that were either untreated or treated with DNA-damaging agents 
(Ichijima et al., 2005; McManus and Hendzel, 2005; Kato et al., 
2008). To  obtain  additional  insights  into  H2AX  produc-
tion during mitosis, we examined H2AX focus formation 
in mitotic cells arising from asynchronously growing cultures of   
human U2OS, HeLa, BJ, and MRC5 cells (Figs. 1 A and S1 A).   
Multiple  discrete  H2AX  foci  were  detected  only  in  mitotic 
cells  that  had  been  exposed  to  IR  or  the  radiomimetic  drug 
phleomycin, but were not readily observed in untreated mitotic 
cells. Some mitotic cells did occasionally display H2AX foci 
under untreated conditions, which could reflect DNA damage 
arising from endogenous sources (Deckbar et al., 2007; Kato 
et al., 2009). As we observed that nocodazole caused an over-
all increase in H2AX levels as detected by immunoblotting   
(Fig. 3 F), we did not use nocodazole to enrich for M-phase cells 
in our subsequent immunofluorescence analyses.
Because H2AX provides a docking site for the DDR- 
mediator protein MDC1 (Stucki et al., 2005), we assessed 
whether MDC1 was recruited to DSB sites in mitosis. Using two 
different anti-MDC1 antibodies, as well as cells stably express-
ing a GFP-MDC1 fusion, we found that, in various cell lines, 
MDC1 colocalized with H2AX foci in mitotic cells that had 
been treated with IR or phleomycin (Figs. 1 B and S1, B–D). 
More detailed analyses revealed that H2AX and MDC1 IRIF 
were present at all mitotic stages (Fig. S1 B). Consistent with 
these observations, we found that the hyperphosphorylated, 
slower migrating forms of MDC1 derived from mitotically   199 DNA DAMAGE RESPONSE IN MITOSIS • Giunta et al.
Figure 1.  ATM and DNA-PK mediate IRIF formation in mitosis. All experiments were performed with U2OS cells. (A) IR induces H2AX focus formation 
on mitotic chromosomes costained for histone H3pS10. (B) ATM inhibitor or a combination of ATM and DNA-PK inhibitors affect H2AX and MDC1 IRIF 
formation in mitosis. (C) Immunoblot of MDC1 after peptide pull-downs with unmodified and phosphorylated H2AX C-terminal peptides. Inputs represent 
10% of the total protein in the whole cell extracts prepared from asynchronous (AS) and mitotic (M) cells. HNE, HeLa nuclear extract. (D) NBS1 and H2AX 
colocalize on mitotic chromosomes after IR.JCB • VOLUME 190 • NUMBER 2 • 2010   200
Figure 2.  53BP1 is excluded from IRIF during mitosis. White arrows point to mitotic cells. (A) Costaining of either mock- or IR-treated asynchronously 
growing U2OS cells with 53BP1 and H2AX antibodies. Phleomycin-treated U2OS cells costained for 53BP1 and MDC1. (B) Enlarged images of mi-
totic cells show exclusion of 53BP1 from chromatin and a lack of colocalization between the punctate 53BP1 staining and H2AX foci. The histogram   201 DNA DAMAGE RESPONSE IN MITOSIS • Giunta et al.
Plans et al., 2008), suggest that RNF8 plays important roles   
in the regulation of mitosis that might be independent of its   
involvement in the DDR. Consistent with the exclusion of 
RNF8 and RNF168 from IRIF during mitosis, the ubiquitin 
E3 ligase BRCA1 was also undetectable in mitotic H2AX 
foci (Fig. 3 C). Importantly, there were no marked changes in 
53BP1, BRCA1, RNF8, or RNF168 protein levels throughout 
the cell cycle (Fig. 3 D), although all these proteins have al-
tered gel migration properties during M phase, likely reflecting 
hyperphosphorylation in mitosis that is characteristic of many 
proteins (Poon, 2007). Furthermore, H2AX foci in mitotic 
cells did not display costaining with the FK2 antibody that de-
tects protein–ubiquitin conjugates, which implies that ubiqui-
tin conjugates are not effectively formed in DSB foci during 
mitosis (Fig. 3 E).
RNF8  and  RNF168  ubiquitylate  nucleosomal  histones 
H2A and H2AX at DSB sites (Stewart, 2009). Previous work 
has shown that ubiquitylated H2A (ubH2A) is essentially absent 
from mitotic chromatin and that active H2A deubiquitylation at the 
G2/M transition is required for chromatin condensation (Matsui   
et al., 1979; Cai et al., 1999; Joo et al., 2007). In agreement with 
these findings, we observed a drastic reduction in ubiquitylated 
H2A and H2AX in mitotic cells, before or after irradiation 
(Fig. 3 F), despite ubiquitin levels being similar throughout the 
cell cycle (unpublished data). Collectively, these data suggest that 
ubiquitylation at DSB sites does not take place in mitosis; this 
is possibly to prevent changes in chromatin conformation in the 
context of highly condensed mitotic chromosomes, which might 
otherwise perturb mitotic progression. The lack of RNF8 recruit-
ment to DSB sites in mitosis could be caused by a combination of 
chromatin structure and mitosis-specific posttranslational modi-
fications (Fig. S3 D), as well as sequestration of RNF8 in mitotic 
structures (Fig. 3, G and H).
Mitotic cells mark DSBs before full DDR 
activation in G1
The progression of mitotic cells into G1 is not apparently de-
layed by DSBs (Fig. S3 E), which supports the idea of a lack 
of  the  DNA  damage  checkpoint  during  mitosis  (Rieder  and 
Cole, 1998; Mikhailov et al., 2002). Indeed, we found that DSB- 
induced phosphorylations of ATM substrates, including the criti-
cal DDR effectors Chk1 and Chk2, occurred to a lesser extent in 
mitotic cells than in interphase cells (Fig. 4 A), despite ATM auto-
phosphorylation on S1981 and formation of H2AX-containing 
IRIF. Interestingly, in line with the lack of 53BP1 recruitment, 
ATM-mediated 53BP1 S25 phosphorylation was not induced by 
DNA damage in mitotic cells (Fig. 4 A). Attenuation of certain 
ATM-mediated phosphorylations in mitosis is in agreement with 
a recent study by van Vugt et al. (2010).
To see whether DSBs carried over from mitosis can trig-
ger full DDR activation in G1, we collected mitotic cells from 
whereas a large proportion of cells damaged in mitosis progress 
into G1 within the 2-h time frame. In contrast, when the G2/M 
checkpoint  was  inactivated  by  preincubating  cells  with  Chk1 
inhibitor  before  phleomycin  treatment,  the  mitotic  index  was 
restored to 1.2%, as had been observed previously in combina-
tion with other DNA-damaging agents (Zabludoff et al., 2008). 
This  result  thereby  implied  that  the  majority  of  such  mitotic 
cells  would  have  arisen  from  damaged  G2  cells  progressing 
into mitosis within the 2-h phleomycin treatment. Under these 
experimental settings, where damaged cells with an inhibited   
G2/M checkpoint entered mitosis, we still did not observe 53BP1 
foci in mitotic cells (Fig. 2 C). These data are in agreement with 
a recent report demonstrating that 53BP1 dissociates from en-
dogenously arising DSBs at the G2/M boundary (Nelson et al., 
2009), and suggest that 53BP1 is actively removed from mitotic 
chromatin even though the known 53BP1-binding histone marks 
H3K79me2 and H4K20me2 (FitzGerald et al., 2009) are retained 
in mitosis (Fig. 3 F).
In  addition,  we  used  live-cell  imaging  of  asynchronous 
U2OS cells stably expressing GFP-53BP1 to assess 53BP1 locali-
zation after cells irradiated during mitosis subsequently en-
tered G1 (Fig. 2 D). Interphase cells present in the field next to   
M-phase cells formed 53BP1 foci within several minutes after 
irradiation. In contrast, 53BP1 signal remained diffuse in mitotic 
cells until division was complete and nuclei reformed as cells en-
tered G1, at which stage 53BP1 started accumulating within IRIF 
(Figs. 2 D and 4 B). 53BP1 focus induction in the G1 cells was 
not caused by the imaging process itself, as it did not occur after 
prolonged imaging of unirradiated cells (Fig. S3 C). Collectively, 
these findings suggest that inhibition of 53BP1 recruitment to 
DSBs is limited to mitosis, and that association of 53BP1 with 
IRIF is concomitant with nuclear envelope formation and chro-
matin decompaction in G1.
E3 ubiquitin ligases RNF8 and RNF168 
are not recruited to mitotic IRIF
Recent work has demonstrated that the ubiquitin E3 ligases 
RNF8 and RNF168 are needed for the productive association 
of 53BP1 and BRCA1 with IRIF (Stewart, 2009). Strikingly, 
by using U2OS cells stably expressing GFP-RNF8 or GFP-
RNF168, we found that both proteins were excluded from mi-
totic chromatin and did not colocalize with H2AX foci upon 
IR or phleomycin treatment (Fig. 3, A and B), even though 
the RNF8 docking site provided by MDC1 phosphorylated on 
the TQXF motifs (Kolas et al., 2007) appears to be constitu-
tively present in mitotic cells (Fig. S2 D). Further examination   
revealed that in addition to the previously reported midbody 
localization (Tuttle et al., 2007; Plans et al., 2008), GFP-RNF8 
associated with other mitotic structures: kinetochores and centro-
somes (Fig. 3, G and H). Our data, together with the proposed 
function of RNF8 in mitotic exit control (Tuttle et al., 2007; 
represents a quantification of H2AX, MDC1, and 53BP1 focus-positive mitotic cells after IR treatment from three independent experiments (n > 200). 
Error bars indicate standard deviation. (C) Active exclusion of 53BP1 from mitotic IRIF. After a 3-h incubation with 50 nM of Chk1 inhibitor (Chk1i), cells 
were treated with phleomycin for 2 h, fixed and costained for 53BP1 and H2AX, or collected for FACS analyses to determine mitotic indices by H3 pS10 
immunofluorescence (purple boxes). (D) Time-lapse frames of U2OS cells stably expressing EGFP-53BP1. After irradiation with 0.5 Gy, two mitotic cells 
marked with arrows were imaged for up to 3 h.
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Figure 3.  Lack of recruitment of the ubiquitin E3 ligases RNF8, RNF168, and BRCA1 to DSB sites in mitosis. (A–C) GFP-RNF8 (A), GFP-RNF168 (B), and 
BRCA1 (C) are excluded from chromatin and are not recruited to IRIF upon DSB induction during mitosis. White arrows indicate mitotic cells. (D) Levels 
of indicated proteins throughout the cell cycle. M-phase cells, obtained by a shake-off procedure after thymidine-nocodazole arrest, were released into 
fresh medium and collected at specified times. (E) FK2 antibody staining does not detect ubiquitin conjugates on mitotic chromosomes upon IR treatment. 
(F) Histones H2A and H2AX are deubiquitylated in mitosis. Arrows point to nonubiquitylated forms and asterisks mark ubiquitylated forms of the proteins. 
Note that histone H4K20me2 and H3K79me2 marks are present in mitosis. (G) GFP-RNF8 colocalizes with CENP-F at kinetochores. (H) GFP-RNF8 local-
izes to centrosomes.203 DNA DAMAGE RESPONSE IN MITOSIS • Giunta et al.
Figure 4.  Marking of DSBs in mitosis precedes full DDR activation in G1 and affects cell survival. Mitotic cells were obtained as in Fig. 3 D. (A) Diminished 
phosphorylation of ATM targets in IR-treated mitotic cells compared with asynchronous cells. (B) Untreated or irradiated mitotic cells were released from 
nocodazole and monitored for cell cycle progression and 53BP1 recruitment to IRIF (see text for details). (C) Chk2 T68 and 53BP1 S25 phosphorylation in 
cells released into G1 after IR treatment in mitosis. (D) Radiosensitivity of asynchronous and mitotic cells pretreated for 1 h with DMSO or a combination of 
ATM and DNA-PK inhibitors and then exposed to various doses of IR. 30 min after irradiation, inhibitors were washed away and cells were plated in fresh 
medium. Error bars represent standard deviations of the mean from six experiments. P-values were calculated at the standard 0.05 threshold. Treatment 
with PIKK inhibitors had statistically significant effects on radiosensitivity of both asynchronous (P = 0.00015) and mitotic (P = 0.041) cells.JCB • VOLUME 190 • NUMBER 2 • 2010   204
Figure 5.  Transient inhibition of ATM and DNA-PK during mitosis before irradiation results in the increase of persistent IRIF 24 h after treatment. U2OS 
cells were treated as in Fig. 4 D. (A) Representative images of the cells at different times after nocodazole and PIKK inhibitor release. The table (B) and the 
graph (C) summarize H2AX focus quantification. Error bars represent standard errors (SE = SD/√n).205 DNA DAMAGE RESPONSE IN MITOSIS • Giunta et al.
the context of highly condensed mitotic chromosomes. Never-
theless, mitotic cells do activate early DDR events, including 
the marking of DSBs by H2AX, MDC1, and MRN, which 
may facilitate recognition of DNA damage and its repair during 
the following cell cycle.
Materials and methods
Cell culture
U2OS, HeLa, BJ, and MRC5 cells were cultured in standard Dulbecco’s 
modified  Eagle’s  minimal  essential  medium  (Sigma-Aldrich)  supple-
mented with 10% FBS (BioSera), 2 mM l-glutamine, 100 U/ml penicil-
lin, and 100 µg/ml streptomycin (Sigma-Aldrich). The medium for U2OS 
cells stably expressing GFP-MDC1 (Kolas et al., 2007), GFP-53BP1, GFP-
RNF8 (Mailand et al., 2007) and GFP-RNF168 was supplemented with   
0.5 mg/ml G418 (Invitrogen).
Treatment with small-molecule inhibitors and DNA-damaging agents
ATM  KU-55933  and  DNA-PK  NU-7441  inhibitors  were  obtained  from   
KuDOS Pharmaceuticals, and Chk1/2 inhibitor AZD7762 was obtained 
from AstraZeneca (Zabludoff et al., 2008). IR treatment was performed 
with  an  x-ray  machine  (Faxitron  X-Ray  LLC).  Phleomycin  (Duchefa  Bio-
chemie) was added at 30 µg/ml. Where appropriate, ATM and DNA-PK   
inhibitors (20 µM and 2 µM, respectively) were applied to the culture   
medium 1 h before DSB induction. Chk1 inhibitor was added (50 nM final 
concentration) 3 h before phleomycin treatment. Cells were processed for 
analyses 30 min after IR or phleomycin treatment.
Cell synchronization
After a 20–24-h presynchronization with 2.5 mM thymidine, cells were 
extensively  washed  and  released  into  fresh  medium.  After  8–10  h,   
nocodazole was added (final concentration 40 ng/ml) for 3–4 h to ac-
cumulate cells in early mitosis.
Immunofluorescence analyses
Cells were either grown on coverslips or harvested by mitotic shake-off and 
attached to poly-l-lysine–coated coverslips using a cytospin centrifuge at 
500 rpm for 5 min. All the following procedures were performed at room 
temperature.  Cells  were  fixed  with  2%  paraformaldehyde  for  20  min, 
washed three times with PBS, permeabilized with 0.2% Triton X-100 in PBS 
for 5 min, and blocked with 5% BSA in PBS/0.1% Tween 20 for 10 min. 
Primary antibodies used are listed in Table S1. Incubation with primary anti-
bodies was for 45 min followed by three washes with PBS and a 30-min 
incubation with the corresponding secondary antibodies: Alexa Fluor 488 
(green), 594 (red), and 647 (far red) at 1:1,000 (Invitrogen). Coverslips 
were washed three times with PBS and mounted with Vectashield mounting 
medium containing DAPI (Vector Laboratories). Images were acquired with 
a confocal microscope (Radiance 2100; BioRad Laboratories) with a 40× 
or 60× objective and processed by Photoshop (Adobe).
Immunoblotting
Standard procedures were used. Cells were lysed in 2× Laemmli buffer 
(Laemmli, 1970), and samples were resolved by SDS-PAGE, transferred 
onto  polyvinylidene  fluoride  or  nitrocellulose  membranes,  and  probed 
with primary antibodies (Table S1). Secondary antibodies were obtained 
from Dako.
Peptide pull-downs
Peptide pull-downs were performed as described previously (Stucki et al., 
2005). To prepare whole-cell extracts (WCEs), U2OS cells were harvested 
by mitotic shake-off or scraped in PBS, washed with PBS, and lysed in 
buffer containing 420 mM NaCl, 20 mM Hepes, pH 7.9, 25% glycerol, 
0.1 mM EDTA, 5 mM MgCl2, 0.2% NP-40 supplemented with protease 
(Roche), and phosphatase (Sigma-Aldrich) inhibitors for 30 min on ice. 
Lysates were cleared by centrifugation at 13,000 rpm for 15 min at 4°C. 
1 mg of U2OS WCE or HeLa nuclear extract (CilBiotech) was incubated 
with  peptide-coupled  beads.  Beads  were  washed  extensively  with  Tris- 
buffered saline (pH 7.5) containing 0.1% Tween 20, and bound proteins 
were eluted in SDS sample buffer.
FACS
Cells  were  fixed  with  70%  ethanol  at  4°C  followed  by  incubation  for   
30 min with 250 µg/ml RNase A and 10 µg/ml propidium iodide at 
a presynchronized culture, treated them with IR, released them 
from nocodazole block, and then analyzed samples at different 
times for cell cycle distribution, presence of 53BP1 in IRIF, and 
Chk2 phosphorylation (Fig. 4, B and C). Cells damaged in   
M phase progressed into G1 with kinetics similar to those of un-
treated cells for up to 5 h after nocodazole release (Fig. 4 B). 
Consistent with full DDR activation occurring when cells entered 
G1, irradiated cells exhibited slower entry and/or progression 
through S-phase, as well as a delay in G2 (Fig. 4 B; 10–24 h time-
points). Similar to our findings with EGFP-53BP1 in live-cell 
imaging experiments (Fig. 2 D), endogenous 53BP1 started form-
ing foci 1–2 h after G1 entry (Fig. 4 B). Furthermore, IRIF were 
still  detectable  24  h  after  irradiation,  although  fewer  foci  re-
mained, which is indicative of ongoing DSB repair. Parallel ex-
amination of IR-induced Chk2 phosphorylation on threonine 68 
(T68) revealed that this modification was reduced in M phase in 
comparison with asynchronous cells (Fig. 4 C). Nevertheless, 
once cells progressed into G1, T68 became highly phosphory-
lated, which supports the notion that an attenuated DDR during 
mitosis becomes fully activated in the following interphase.
To assess the potential physiological significance of DSB 
marking in mitosis, we performed clonogenic survival assays on 
asynchronous and mitotic cells that had been irradiated either in 
the absence or presence of ATM and DNA-PK inhibitors (Fig. 4 D). 
In agreement with earlier studies (Stobbe et al., 2002), mitotic 
cells displayed much higher radiosensitivity compared with asyn-
chronous cells. Furthermore, acute PIKK inhibition, at a dose suf-
ficient to ablate H2AX IRIF formation, further enhanced the 
killing of mitotic and asynchronous cells.
To assess how PIKK inhibition during mitosis leads to   
radiosensitization, we quantified H2AX foci at various time 
points after release from inhibitor treatment and nocodazole 
block. The inhibitors were removed 30 min after irradiation, 
and the effect of PIKK inhibition on H2AX was readily revers-
ible within 1 h (Fig. 5 A). Notably, at the 1 h time point, similar 
numbers of foci were present in cells that had been mock- or 
PIKK inhibitor–treated (Fig. 5 A), which indicates that similar 
amounts of damage were generated under the two conditions, 
and that the majority of DSBs formed in mitosis were not re-
paired before G1 entry. Lack of ongoing DSB repair in mitosis 
is also supported by the difference in PIKK inhibitor–mediated 
radiosensitization between asynchronous and mitotic cells: the 
effect of the PIKK inhibitors on mitotic cells is approximately 
threefold lower than on asynchronous cells (Fig. 4 D). At later 
time points, however, there were significant differences in IRIF 
numbers between mock- and inhibitor-treated cells, with the   
inhibitor-treated cells showing twofold more residual foci at the 
24 h time point (Fig. 5, B and C). One possibility is that the 
IRIF that persist after 24 h in cells derived from mitotic cells 
pretreated with PIKK inhibitors correspond to more complex 
lesions that might otherwise have benefited from the immediate 
marking after DNA damage induction.
Collectively, our data support a model in which mitotic 
cells treated with DSB-inducing agents prioritize timely pas-
sage through mitosis over activation of a full DDR. The latter is 
likely to involve substantial changes in chromatin structure 
proximal to DSB sites that would presumably not be feasible in JCB • VOLUME 190 • NUMBER 2 • 2010   206
37°C. Cells were analyzed by FACS on a CyAn flow cytometer (Beckman 
Coulter). Data were analyzed with FlowJo software (Tree Star, Inc.).
Live cell imaging
Cells were cultured in 35 mm Ibidi dishes (Thistle Scientific) in phenol red-
free medium (Invitrogen). Images were acquired with an inverted micro-
scope (Axiovert 200 M; Carl Zeiss, Inc.) equipped with a 37°C heated 
stage  and  CO2  chamber  (PeCon  GmbH)  and  LSM510  software  (Carl 
Zeiss, Inc.).
Cell survival assays
Mitotic  cells  obtained  by  shake-off  of  the  cultures  presynchronized  by   
thymidine-nocodazole were treated with ATM and DNA-PKcs inhibitors   
for 1 h and irradiated with 0.5, 1, 2, or 4 Gy. 30 min later, cells were 
extensively washed to remove inhibitors and/or nocodazole, counted, and 
plated. Asynchronous cells were plated 24 h before the treatments. Cells 
were left for 10–14 d at 37°C to allow colony formation. Colonies were 
stained with 0.5% crystal violet/20% ethanol and counted. Results were 
normalized to plating efficiencies. Statistical analysis was performed using 
the R Language for Statistical Computing. Coefficients and corresponding   
p-values were calculated separately for mitotic and asynchronous cells using 
the linear modeling function in R by the following model: log(y) = 0 + 1IR + 
2IR
2 + 3t + 4IR × t, where y is the percentage of cells surviving, IR is 
the radiation level in Gy, and t is the treatment (encoded as 0 for DMSO 
and 1 for ATMi/DNA-PKi). The quadratic term was included because the 
response curve is nonlinear.
Immunoprecipitation
For ATM immunoprecipitation (Fig. S2 C), cells were lysed for 30 min on 
ice in buffer containing 20 mM Hepes, pH 7.9, 450 mM NaCl, 1.5 mM 
MgCl2, 1 mM EGTA, 0.1% Tween 20, 10% glycerol, Ser-Thr phosphatase 
inhibitor cocktail (Sigma-Aldrich), and protease inhibitor cocktail (Roche). 
Extracts were cleared by centrifugation at 14,000 rpm for 30 min at 4°C 
and diluted with the same buffer lacking NaCl to a final concentration of 
150 mM NaCl. Extracts were subsequently incubated with Protein G–
coated Dynabeads (Invitrogen) prebound with antibodies for 2 h at 4°C. 
After five washes with the immunoprecipitation buffer, beads were boiled 
for  5  min  in  SDS  sample  buffer.  Eluted  proteins  were  resolved  by   
4–8% gradient SDS-PAGE and transferred to polyvinylidene fluoride mem-
brane (GE Healthcare). Immunoblotting was performed with the appropri-
ate antibodies (Table S1).
Online supplemental material
Fig. S1 supplements the data in Fig. 1 (A and B), demonstrating formation of 
H2AX- and MDC1-containing IRIF in mitotic HeLa, BJ, and MRC5 cells upon 
DSB induction. Fig. S2 contains controls for the data presented in Fig. 1   
(C and D): the effect of the ATM and DNA-PK inhibitors on IRIF formation and 
DDR markers in the asynchronously growing U2OS cells, IR-induced ATM 
phosphorylation on S1981 in mitosis, and MDC1 phosphorylation on TQXF 
motif during mitosis. Fig. S3 supplements Fig. 2 by providing additional 
examples of 53BP1 exclusion from IRIF in mitotic cells derived from various 
cell lines and the “untreated” control for the time-lapse images; Fig. S3 also 
shows altered gel mobility of RNF8 in mitosis and lack of delay in mitotic 
exit following irradiation of the mitotic cells. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200911156/DC1.
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